Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
- 24 December 2009
- journal article
- Published by Elsevier BV in Neuron
- Vol. 64 (6), 807-827
- https://doi.org/10.1016/j.neuron.2009.11.006
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's diseaseNature Neuroscience, 2009
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in DrosophilaThe EMBO Journal, 2008
- A Drosophila model for LRRK2 -linked parkinsonismProceedings of the National Academy of Sciences of the United States of America, 2008
- The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubulesJournal of Neuroscience Research, 2008
- LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activityBiochemical Journal, 2007
- Leucine‐rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutantsJournal of Neurochemistry, 2007
- Selective fluorescent imaging of superoxide in vivo using ethidium-based probesProceedings of the National Academy of Sciences of the United States of America, 2006
- α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's ModelsScience, 2006
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996